MarketScreener Homepage > Equities > Nasdaq > Assertio Holdings, Inc. ASRT

Report

Delayed Nasdaq - 01/15 04:00:01 pm
0.5901	USD		-6.33%

2020

ASSERTIO HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)

2020

ASSERTIO : Significant Insider Selling in Shares of Assertio Holdings (ASRT) Continues

2020

INSIDER TRENDS : Selling By Insiders Lingers at Assertio Holdings

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

01/11/2021	01/12/2021	01/13/2021	01/14/2021	01/15/2021	Date
0.5999(c)	0.6148(c)	0.6741(c)	0.63(c)	0.5901(c)	Last
18 974 572	14 223 416	15 647 149	8 981 392	6 372 450	Volume
+11.30%	+2.48%	+9.65%	-6.54%	-6.33%	Change

More quotes

Financials (USD)

Sales 2020	107 M - -
Net income 2020	-9,04 M - -
Net cash position 2020	60,0 M - -
P/E ratio 2020	-6,56x
Yield 2020	-

Sales 2021	112 M - -
Net income 2021	-12,5 M - -
Net cash position 2021	45,0 M - -
P/E ratio 2021	-5,90x
Yield 2021	-

Capitalization	63,3 M 63,3 M -
EV / Sales 2020	0,03x
EV / Sales 2021	0,16x
Nbr of Employees	125
Free-Float	95,8%

More Financials

Company

Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is...

Sector

Pharmaceuticals

Calendar

More about the company

All news about ASSERTIO HOLDINGS, INC.

2020	ASSERTIO HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
2020	ASSERTIO : Significant Insider Selling in Shares of Assertio Holdings (ASRT) Con..	MT
2020	INSIDER TRENDS : Selling By Insiders Lingers at Assertio Holdings	MT
2020	ASSERTIO : Given Until June 28 to Meet $1 Minimum Bid Rule to Maintain Nasdaq Li..	MT
2020	ASSERTIO HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued ..	AQ
2020	Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Na..	GL
2020	INSIDER TRENDS : Insider 90-Day Selling Trend Continued at Assertio Holdings	MT
2020	ASSERTIO : Therapeutics Declines Amid Restructuring Plan; CEO Resignation	MT
2020	ASSERTIO HOLDINGS, INC. : Costs Associated with Exit or Disposal Activities, Cha..	AQ
2020	ASSERTIO : Announces Restructuring Plan and Leadership Changes	AQ
2020	ASSERTIO : to Present at the Stifel 2020 Virtual Healthcare Conference on Novemb..	AQ
2020	ASSERTIO : to Present at the Stifel 2020 Virtual Healthcare Conference on Novemb..	AQ
2020	Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on Novem..	GL
2020	ASSERTIO : Reports Third Quarter 2020 Financial Results	AQ
2020	ASSERTIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..	AQ

More news

News in other languages on ASSERTIO HOLDINGS, INC.

- No features available -

More news

Provided by Scoopnest.com

Chart ASSERTIO HOLDINGS, INC.

Duration : Period :

Assertio Holdings, Inc. Technical Analysis Chart | ASRT | US04546C1062 | MarketScreener

Full-screen chart

Technical analysis trends ASSERTIO HOLDINGS, INC.

	Short Term	Mid-Term	Long Term
Trends	Bullish	Neutral	Bearish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	2
Average target price	0,75 $
Last Close Price	0,59 $
Spread / Highest target	27,1%
Spread / Average Target	27,1%
Spread / Lowest Target	27,1%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Daniel A. Peisert	President, Chief Executive Officer & Director
Peter D. Staple	Chairman
William T. McKee	Director
James L. Tyree	Director
Heather L. Mason	Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

ASSERTIO HOLDINGS, INC.	65.02%	63



JOHNSON & JOHNSON	1.86%	421 997
ROCHE HOLDING AG	2.48%	305 385
NOVARTIS AG	1.97%	218 041
MERCK & CO., INC.	1.93%	210 954
PFIZER INC.	-0.30%	203 993

More Results